Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36660720)

  • 1. Pan-cancer analysis of
    Jia B; Liu J; Hu X; Xia L; Han Y
    Ann Transl Med; 2022 Dec; 10(24):1355. PubMed ID: 36660720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.
    Lv M; Li X; Yin Z; Yang H; Zhou B
    PLoS One; 2024; 19(4):e0294227. PubMed ID: 38564630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DEP domain containing 1 as a biomarker for poor prognosis in lung adenocarcinoma.
    Li C; Zhu X
    Heliyon; 2024 May; 10(9):e30642. PubMed ID: 38765113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis.
    Zhao G; Song D; Wu J; Yang S; Shi S; Cui X; Ren H; Zhang B
    Front Immunol; 2022; 13():955091. PubMed ID: 36052059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer prognostic model and immune microenvironment analysis of natural killer cell-related genes.
    Li C; Huang Y; Yi X; Tang Y; Okita R; He J
    Transl Cancer Res; 2024 Apr; 13(4):1936-1953. PubMed ID: 38737690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis.
    Lin Y; Zhang Y; Tuo Z; Gao L; Ding D; Bi L; Yu D; Lv Z; Wang J; Chen X
    BMC Cancer; 2023 Mar; 23(1):285. PubMed ID: 36978046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
    Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
    Front Oncol; 2022; 12():927988. PubMed ID: 35756681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer.
    Zhou X; Wang Y; Zheng J; Wang S; Liu C; Yao X; Ren Y; Wang X
    Front Genet; 2022; 13():990301. PubMed ID: 36276934
    [No Abstract]   [Full Text] [Related]  

  • 11. Pan-cancer analysis of the prognostic and immunological role of Fanconi anemia complementation group E.
    Zhou Z; Yin H; Suye S; He J; Fu C
    Front Genet; 2022; 13():1024989. PubMed ID: 36685883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EF-Hand Domain-Containing Protein D2 (EFHD2) Correlates with Immune Infiltration and Predicts the Prognosis of Patients: A Pan-Cancer Analysis.
    Wang Y; Song M; Gao B
    Comput Math Methods Med; 2022; 2022():4878378. PubMed ID: 35341013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-Omics Analysis and Verification of the Oncogenic Value of CCT8 in Pan-Cancers.
    Gong L; Zhong M; Gong K; Wang Z; Zhong Y; Jin Y; Chen H; Tai P; Chen X; Chen A; Cao K
    J Inflamm Res; 2023; 16():2297-2315. PubMed ID: 37273485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
    Ju Q; Li XM; Zhang H; Zhao YJ
    Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of ACBD3 as a new molecular biomarker in pan-cancers through bioinformatic analysis: a preclinical study.
    Ma X; Huang S; Shi H; Luo R; Luo B; Tan Z; Shi L; Zhang W; Yang W; Zhong X; Lü M; Chen X; Tang X
    Eur J Med Res; 2023 Dec; 28(1):590. PubMed ID: 38098097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Integrative Pan-Cancer Analysis of PBK in Human Tumors.
    Wen H; Chen Z; Li M; Huang Q; Deng Y; Zheng J; Xiong M; Wang P; Zhang W
    Front Mol Biosci; 2021; 8():755911. PubMed ID: 34859049
    [No Abstract]   [Full Text] [Related]  

  • 18. Pan-cancer analysis of the prognostic and immunological roles of
    Liu S; Liu Y; Zhang X; Song X; Zhang B; Zhang Y
    Front Genet; 2022; 13():1039440. PubMed ID: 36313454
    [No Abstract]   [Full Text] [Related]  

  • 19. A Pan-Cancer Analysis of the Prognostic Value and Expression of Adenylate Cyclase 7 (ADCY7) in Human Tumors.
    Zeng Y; Li N; Zheng Z; Chen R; Liu W; Zhu J; Zeng M; Cheng J; Peng M; Hong C
    Int J Gen Med; 2021; 14():5415-5429. PubMed ID: 34539183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
    Zhou X; Du J; Liu C; Zeng H; Chen Y; Liu L; Wu D
    Front Immunol; 2021; 12():688215. PubMed ID: 34305920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.